These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3150608)

  • 1. [Post-transfusion Chagas' disease].
    Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1988; 43(3):135-7. PubMed ID: 3150608
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chagas' disease and blood transfusion: trypanocidal activity of maprotiline hydrochloride and gentian violet].
    Celentano AM; González Cappa SM
    Medicina (B Aires); 1988; 48(3):265-8. PubMed ID: 3150028
    [No Abstract]   [Full Text] [Related]  

  • 3. A strategy for the prevention of the transmission of Chagas' disease during blood transfusion.
    Hammond DJ; Croft SL; Hogg J; Gutteridge WE
    Acta Trop; 1986 Dec; 43(4):367-78. PubMed ID: 2882664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and preservation of fresh and stored erythrocytes in blood treated with gentian violet.
    Moraes-Souza H; Kerbauy J; Barretto OC; Pühler GM; Nonoyama K; Juliano Y
    Braz J Med Biol Res; 1988; 21(2):241-6. PubMed ID: 3144400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for prevention of transfusion-associated Chagas' disease.
    Moraes-Souza H; Bordin JO
    Transfus Med Rev; 1996 Jul; 10(3):161-70. PubMed ID: 8809967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Chagas' disease resulting from blood transfusion by treatment of blood: toxicity and mode of action of gentian violet.
    Docampo R; Moreno SN; Gadelha FR; de Souza W; Cruz FS
    Biomed Environ Sci; 1988 Dec; 1(4):406-13. PubMed ID: 3151757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of transfusion-associated Chagas' disease by sterilization of Trypanosoma cruzi-infected blood with gentian violet, ascorbic acid, and light.
    Ramirez LE; Lages-Silva E; Pianetti GM; Rabelo RM; Bordin JO; Moraes-Souza H
    Transfusion; 1995 Mar; 35(3):226-30. PubMed ID: 7878715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canadian Blood Services to screen for Chagas disease.
    Comeau P
    CMAJ; 2007 Jul; 177(3):242. PubMed ID: 17664439
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism and mode of action of gentian violet.
    Moreno SN
    Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():308-20. PubMed ID: 3150994
    [No Abstract]   [Full Text] [Related]  

  • 10. Chagas' disease and blood transfusion.
    Schmuñis GA
    Prog Clin Biol Res; 1985; 182():127-45. PubMed ID: 3929260
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of triphenylmethane dyes on Trypanosoma cruzi in vitro; use of gentian violet in prevention of transmission of Chagas disease by blood transfusion].
    NUSSENZWEIG V; SONNTAG R; BIANCALANA A; DE FREITAS JL; AMATO NETO V; KLOETZEL J
    Hospital (Rio J); 1953 Dec; 44(6):731-44. PubMed ID: 13151630
    [No Abstract]   [Full Text] [Related]  

  • 12. [Post-transfusion Chagas' disease].
    Noziglia del Nido C; Contreras Acuña J; Subercaseaux Sepúlveda B; Joyas Martínez TM
    Rev Chil Pediatr; 1981; 52(4):318-22. PubMed ID: 6805046
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the eventual activity of cyclosporin A in preventing the transmission, by blood transfusion, of Trypanosoma cruzi infection].
    Amato Neto V; Pasternak J; de Souza ER; Costa AM; Matsubara L
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(4):195-6. PubMed ID: 9567370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chagas' disease: lessons from routine donation testing.
    Castro E
    Transfus Med; 2009 Feb; 19(1):16-23. PubMed ID: 19302451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferral aims to deter Chagas' parasite.
    Skolnick A
    JAMA; 1991 Jan; 265(2):173. PubMed ID: 1898525
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfusional chagas disease: parasitological and serological monitoring of an infected recipient and blood donor.
    Flores-Chávez M; Fernández B; Puente S; Torres P; Rodríguez M; Monedero C; Cruz I; Gárate T; Cañavate C
    Clin Infect Dis; 2008 Mar; 46(5):e44-7. PubMed ID: 18257698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemotherapy and transfusional Chagas' disease in Brazil].
    Moraes-Souza H; Wanderley DM; Brener S; Nascimento RD; Antunes CM; Dias JC
    Bol Oficina Sanit Panam; 1994 May; 116(5):406-18. PubMed ID: 8043200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection.
    Leiby DA; Herron RM; Garratty G; Herwaldt BL
    J Infect Dis; 2008 Aug; 198(4):609-13. PubMed ID: 18588482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease.
    Rassi A; Dias JC; Marin-Neto JA; Rassi A
    Heart; 2009 Apr; 95(7):524-34. PubMed ID: 19131444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent data on the use of gentian violet in prevention of the transmission of Chagas'disease by blood transfusion].
    NUSSENZWEIG V; AMATO NETO V; MELLONE O
    Hospital (Rio J); 1959 Feb; 55(2):183-8. PubMed ID: 13640534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.